Showing results (121-130 of 129) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Clinical Transplants|January 1, 1991
Cardiac transplantation at the University of Pittsburgh: 1980 to 1991R L Kormos, J M Armitage, R L Hardesty, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1992
Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertensionS Murali, B F Uretsky, J M Armitage, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosisC A McNamara, I J Sarembock, B G Bachhuber, et al.American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.Circulation|March 15, 1996
Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbitsM Ragosta, W L Barry, L W Gimple, et al.American Heart Journal|July 1, 1997
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)R M Califf, K F Adams, W J McKenna, et al.Circulation|December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study GroupW S Colucci, M Packer, M R Bristow, et al.The New England Journal of Medicine|February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionR J Barst, L J Rubin, W A Long, et al.Circulation|March 18, 1997
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study GroupA L Hinderliter, P W Willis, R J Barst, et al.Pageof 13